Profile
BNGOW DHR-PB TMO DHR IDXX A
Company Name BioNano Genomics, Inc. WT EXP 082123 Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap - $916.76B $203.95B $153.12B $50.25B $36.74B
Employees 0.10K 79.00K 125.00K 61.00K 11.00K 17.90K
CEO - Rainer M. Blair Marc N. Casper Rainer Blair Jonathan J. Mazelsky Padraig McDonnell
Ratings
BNGOW DHR-PB TMO DHR IDXX A
Quant Rating Score 2 5 3 3 3 3
Quant Rating Sell Strong Buy Neutral Neutral Neutral Neutral
Trading
BNGOW DHR-PB TMO DHR IDXX A
Last Close $0.0036 $1261.26 $567.16 $220.44 $669 $144.52
High 52 - $1261.26 $606.74 $250.59 $722.94 $152.6
Low 52 - $1261.26 $390.2 $174.64 $361.04 $99.29
Price vs. 52 Week High 0 % 0 % -6.52 % -12.03 % -7.46 % -5.29 %
Price vs. 52 Week Low 0 % 0 % 45.35 % 26.23 % 85.3 % 45.55 %
Total Return
BNGOW DHR-PB TMO DHR IDXX A
1 Month Return 0 % 0 % 5.24 % 5.44 % 5.29 % 1.83 %
3 Month Return 0 % 0 % 16.29 % 5.47 % 4.88 % 22.32 %
6 Month Return 0 % 0 % 37.64 % 12.41 % 29.13 % 27.03 %
9 Month Return 0 % 0 % 8.42 % 7.78 % 48.98 % 6.89 %
YTD Return 0 % 0 % 9.02 % -3.97 % 61.81 % 7.58 %
1 Year Return 0 % 0 % 11.4 % -4.51 % 60.69 % 14.98 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BNGOW DHR-PB TMO DHR IDXX A
Dividend Yield Percentage (TTM) - 0.58 % 0.32 % 0.59 % - 0.77 %
Dividend Paid and Capex Coverage Ration (TTM) - 3.15 % 3.62 % 3.15 % 9.48 % 2.26 %
Dividend Per Share (TTM) - 1.28 % 1.72 % 1.28 % - 1 %
Payout Ratio (TTM) - 24.29 % 9.47 % 24.29 % - 21.64 %
Growth
BNGOW DHR-PB TMO DHR IDXX A
Asset Growth -64.24 % 7.64 % 13.38 % 7.64 % 1.03 %
Gross Profit Growth -96.03 % 5.38 % -5.36 % 5.38 % 8.63 %
Revenue Growth -14.79 % 2.9 % 3.91 % 2.9 % 6.46 %
Revenue 3 Year -57.67 % -5.47 % 3.42 % -5.47 % 25.23 %
Revenue 5 Year -99.93 % 10.08 % 45.65 % 10.08 % 69.09 %
Revenue 10 Year - 68 % 178.48 % 68 % 218.38 %
EBIT Growth 50.86 % -7.15 % -6.71 % -7.15 % 3.47 %
Net Income Growth 51.82 % -7.31 % 6.35 % -7.31 % 5.07 %
Net Income 3 Yeari Growth Per Share 61.76 % -48.61 % 1.06 % -48.61 % 23.15 %
Net Income 5 Yeari Growth Per Share 99.92 % -1.03 % 11.3 % -1.03 % 116.76 %
Net Income 10 Yeari Growth Per Share - 37.36 % 261.63 % 37.36 % 492.42 %
Operating Income Growth 51.69 % -0.91 % 5.83 % -0.91 % 2.84 %
Operating Cash Flow Growth (CFG) 44.94 % -4.07 % -9.8 % -4.07 % 2.48 %
Operating 3 Year CFG 76.3 % -22.79 % -10.96 % -22.79 % 27.03 %
Operating 5 Year CFG 99.95 % 3.19 % -0.67 % 3.19 % 111.28 %
Operating 10 Year CFG - 66.57 % 194.29 % 66.57 % 378.1 %
EPS Growth 99.64 % -4.88 % 7.18 % -4.88 % 5.9 %
EPS Diluted Growth 99.64 % -4.73 % 7.32 % -4.73 % 6.06 %
Book Value Per Share -88.78 % 9.57 % 9.5 % 9.57 % 8.24 %
Share Holder 3 Year Equity Growth Per Share -97.41 % 7.54 % 26.63 % 7.54 % 138.87 %
Share Holder 5 Year Equity Growth Per Share -99.78 % 31.9 % 63.03 % 31.9 % 838.67 %
Share Holder 10 Year Equity Growth Per Share - 118.87 % 165.29 % 118.87 % 1547.69 %
Dividend Per Share Growth - 18.15 % 10.83 % 18.15 % -
Dividend 3 Year Growth Per Share - 10.04 % 45.73 % 10.04 % -
Dividend 5 Year Growth Per Share - 42.54 % 98.76 % 42.54 % -
Dividend 10 Year Growth Per Share - 144.73 % 180.3 % 144.73 % -
Debt Growth -65.63 % 7.42 % 20.17 % 7.42 % -7.53 %
Free Cash Flow Growth 45.59 % -0.68 % -13.4 % -0.68 % 3.26 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2025 31 Dec 2025 31 Dec 2024
Profitability
BNGOW DHR-PB TMO DHR IDXX A
Gross Profit Margin TTM 46.51 % 60.93 % 39.46 % 60.93 % 61.8 % 52.43 %
Return on Assets TTM -48.81 % 4.33 % 6.09 % 4.33 % 31.62 % 10.24 %
Return on Equity TTM -86.36 % 6.99 % 13.14 % 6.99 % 69.78 % 20.62 %
Return on Capital Employed TTM -65.51 % 6.7 % 8.41 % 6.7 % 61.76 % 14.25 %
Net Income Per EBT TTM 100.08 % 85.38 % 92.39 % 85.38 % 80.01 % 90.8 %
EBT Per Ebit TTM 104.93 % 82.4 % 90.83 % 82.4 % 97.36 % 97.03 %
EBIT Per Revenue TTM -127.94 % 20.91 % 17.96 % 20.91 % 31.6 % 21.29 %
Cash Flow To Debt Ratio TTM -253.38 % 34.84 % 19.85 % 34.84 % 139.39 % 46.48 %
Receivables Turnover TTM 6.35 6.28 5.01 6.28 7.79 4.67
Payables Turnover TTM 2.56 5.2 - 5.2 14.89 5.8
Inventory Turnover TTM 2.18 3.86 4.97 3.86 4.35 3.22
Fixed Asset Turnover TTM 125.88 % 444.19 % 421.73 % 444.19 % 575.84 % 343.45 %
Asset Turnover TTM 36.33 % 29.44 % 40.38 % 29.44 % 128.44 % 54.59 %
Operating Cash Flow Per Share TTM -3.5 9.07 20.79 9.07 14.75 5.51
Free Cash Flow Per Share TTM -3.5 7.44 16.74 7.44 13.2 4.07
Cash Per Share TTM 57.42 % 652.48 % 2687.5 % 652.48 % 224.82 % 632.16 %
Operating Cash Flow Sales Ratio TTM -65.02 % 26.12 % 17.55 % 26.12 % 27.46 % 22.44 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 81.98 % 80.49 % 81.98 % 89.45 % 73.89 %
Cash Flow Coverage Ratios TTM -253.38 % 34.84 % 19.85 % 34.84 % 139.39 % 46.48 %
Price To Free Cash Flows Ratio TTM -0.21 29.56 32.41 29.11 47.54 31.89
Price To Operating Cash Flows Ratio TTM -0.34 24.25 26.11 23.88 42.65 23.52
Price Cash Flow Ratio TTM -0.34 24.25 26.11 23.88 42.65 23.52
Income Statement (TTM)
BNGOW DHR-PB TMO DHR IDXX A
Revenue $0.03B $24.57B $44.56B $24.57B $4.3B $6.95B
Gross Profit $0B $14.97B $16.78B $14.97B $2.66B $3.64B
Gross Profit Ratio 1.23% 60.93% 37.66% 60.93% 61.8% 52.43%
EBITDA $-0.1B $6.95B $10.89B $6.95B $1.47B $1.84B
Net Income $-0.11B $3.61B $6.74B $3.61B $1.06B $1.3B
EPS Diluted -88.13 5.04 17.74 5.04 13.08 4.57
Balance Sheet (MRQ)
BNGOW DHR-PB TMO DHR IDXX A
Long Term Debt $0B $18.42B $35.85B $18.42B $0.37B $3.05B
Total Liabilities $0.04B $30.93B $56.81B $30.93B $1.75B $5.99B
Total Equity $0.04B $52.54B $53.54B $52.54B $1.61B $6.74B
Total Investments $0B $0B $0.25B $0B $0B $0.13B
Total Debt $0.03B $18.42B $39.39B $18.42B $0.85B $3.35B
Total Assets $0.08B $83.46B $110.34B $83.46B $3.35B $12.73B
Cash Flow Statement (TTM)
BNGOW DHR-PB TMO DHR IDXX A
Net Income $-0.11B $3.61B $6.72B $3.61B $1.06B $0.43B
Inventory $-0B $-0.06B $0B $-0.06B $0B $0.05B
Dividends Paid $0B $-0.88B $-0.64B $-0.88B $0B $-0.28B
Operating Cash Flow $-0.07B $6.42B $7.82B $6.42B $1.18B $1.56B
Capital Expenditure $-0B $-1.16B $-1.53B $-1.16B $-0.12B $-0.41B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 125.81
ACRS Aclaris Therapeutics, Inc. 3.19
ADVB Advanced Biomed Inc. Common Stock 0.2401
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 5.62
AWH Aspira Women's Health Inc. 0.082
BDSX Biodesix, Inc. 11.45
BIAF bioAffinity Technologies, Inc. 1.04
BIAFW bioAffinity Technologies, Inc. 0.2258
BIOC Biocept, Inc. 0.4349
BLLN BillionToOne, Inc. 88.61
BNGO Bionano Genomics, Inc. 1.1
BNR Burning Rock Biotech Limited 29.135
CDNA CareDx, Inc 19.63
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 1.68
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 161.35
CSTL Castle Biosciences, Inc. 33.15
Unlock